Skip to content Skip to footer

Close

Sartar was granted a Japan patent

January 25, 2019

Sartar was awarded a patent in Japan for the use of anagrelide in cancer therapy.

Tags: growth innovation life science patent research start-up technology

You May Also Like

Business Finland granted Sartar R&D Funding

Sartar’s therapy method featured in Drug Target Review

Sartar Therapeutics investment round was a success